Capra Biosciences
PrivateLast Round
Grant
Jul 19, 2024
Total Funding Raised
$10.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Capra Biosciences operates in Healthcare & Life Sciences and is based in Sterling, Virginia. Its latest recorded funding round was a Seed round in April 2024.
Capra Biosciences is a biotechnology company that develops a proprietary bioreactor platform to produce sustainable, bio-based chemicals as alternatives to petrochemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Capra Biosciences Comparables
Compare Capra Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZymoChem | 81% | |
| TripleW | 78% | |
| Manus Bio | 73% |
For institutional investors. Book with your work email.
Capra Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 19, 2024 | ||||
| Seed | Apr 29, 2024 | ||||
| Seed | Dec 12, 2023 | ||||
| Grant | Apr 24, 2023 | ||||
| Pre Seed | Jun 6, 2022 | ||||
Accelerator | Mar 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Capra Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| GS Futures | Seed, Pre Seed |
| Administration for Strategic Preparedness and Response | Grant |
| Schmidt Futures | Grant |
| Groundswell Ventures | Seed |
| IndieBio | Accelerator |
| Asymmetry Ventures | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Grew 17% QoQ, from 23 to 27 employees.
- Jul 25, 2026
Monthly visitors grew 104% MoM, reaching 753.
For institutional investors. Book with your work email.
Capra Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Capra Biosciences's valuation, stock price, and market status.
Is Capra Biosciences a public or private company?
Capra Biosciences is a private company.
What is the current stock price of Capra Biosciences?
Capra Biosciences is a private company, so its shares have no public market price. Caplight tracks Capra Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Capra Biosciences worth (valuation)?
Valuation information for Capra Biosciences is not publicly available.
Can I buy Capra Biosciences stock?
Capra Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Capra Biosciences's last funding round?
Capra Biosciences's most recent funding round was Grant on July 19, 2024.
Who are the main investors in Capra Biosciences?
Key investors in Capra Biosciences include U.S. Department of Health and Human Services, IndieBio, Closed Loop Partners.
Will Capra Biosciences IPO soon?
No public IPO plans have been announced for Capra Biosciences.
How can I track Capra Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Capra Biosciences's shares on secondary markets.